The Wall Street Journal: The Wall Street Journal: Moderna Developing Vaccine Booster Shot For Virus Strain Identified In South Africa
Moderna Inc. said its Covid-19 vaccine appeared to protect against emerging
variants of the coronavirus in laboratory tests, but as a precaution it would
test whether a booster shot improves immune responses and develop a new vaccine
targeting the strain first identified in South Africa. The company said Monday
its vaccine produced immune-system agents known as neutralizing antibodies that
worked against the emerging virus variants tested, including strains first
evident in the U.K. and South Africa. (Loftus, 1/25)
Moderna Inc. said its Covid-19 vaccine appeared to protect against emerging
variants of the coronavirus in laboratory tests, but as a precaution it would
test whether a booster shot improves immune responses and develop a new vaccine
targeting the strain first identified in South Africa. The company said Monday
its vaccine produced immune-system agents known as neutralizing antibodies that
worked against the emerging virus variants tested, including strains first
evident in the U.K. and South Africa. (Loftus, 1/25)
No comments:
Post a Comment